Literature DB >> 1391984

Integrating prognostic factors.

G M Clark1.   

Abstract

This special issue of Breast Cancer Research and Treatment addresses the topic of how to evaluate new prognostic factors for breast cancer, and how the information provided by these new factors might be integrated with traditional factors to make better treatment decisions for these patients. Although the focus is on breast cancer, the techniques described are equally applicable to any situation involving survival or failure over time.

Entities:  

Mesh:

Year:  1992        PMID: 1391984     DOI: 10.1007/bf01840831

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  1 in total

1.  Breast cancer prognostic factors: evaluation guidelines.

Authors:  W L McGuire
Journal:  J Natl Cancer Inst       Date:  1991-02-06       Impact factor: 13.506

  1 in total
  4 in total

1.  Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results.

Authors:  M Bolla; B Rostaing-Puissant; S P Bottari; M Chedin; J Marron-Charriere; M Colonna; E Berland; E Chambaz
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Protein tyrosine kinase activity as a prognostic parameter in breast cancer, a pilot study.

Authors:  M Bolla; B R Rostaing-Puissant; M Chedin; C Souvignet; J Marron-Charriere; M Colonna; E Berland; E M Chambaz
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

3.  Coexpression of HER-2/neu and p53 is associated with a shorter disease-free survival in node-positive breast cancer patients.

Authors:  C Wiltschke; I Kindas-Muegge; A Steininger; A Reiner; G Reiner; P N Preis
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Differences between the clinical and histopathological tumor stages in breast cancer diagnosed using vacuum-assisted breast biopsy.

Authors:  Hai-Lin Park; Ji-Sun Hong; So Yong Chang; Jung Yin Huh; Ji Eun Shin; Ji-Young Kim; Jeong Yun Shim; Songmi Noh
Journal:  Oncol Lett       Date:  2015-02-09       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.